US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.190
  • +0.060+1.92%
Close Dec 20 16:00 ET
  • 3.190
  • 0.0000.00%
Post 16:13 ET
269.44MMarket Cap-1.54P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atea Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.49
-0.37
+0.12
Beat Est.
-23.28%
+7.50%
+24.95%
Analyst Rating
Hold

Nov 30, 2024

Atea Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Atea Pharmaceuticals Earnings Reports

  • Atea Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8 11:38

  • Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 8 05:33

  • Atea Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 04:52

  • Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 8 04:23

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data